These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 8013987)
41. Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders. Mobini N; Sarela A; Ahmed AR Ann Allergy Asthma Immunol; 1995 Feb; 74(2):119-28; quiz 128-33. PubMed ID: 7697470 [TBL] [Abstract][Full Text] [Related]
42. IVIG-mediated effector functions in autoimmune and inflammatory diseases. Galeotti C; Kaveri SV; Bayry J Int Immunol; 2017 Dec; 29(11):491-498. PubMed ID: 28666326 [TBL] [Abstract][Full Text] [Related]
43. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin. Rütter A; Luger TA J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915 [TBL] [Abstract][Full Text] [Related]
44. [Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies]. Siwińska-Gołebiowska H; Czerwińska-Kartowicz I; Markiewicz K Postepy Hig Med Dosw; 2002; 56 Suppl():33-40. PubMed ID: 12661412 [TBL] [Abstract][Full Text] [Related]
46. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know? Crow AR; Lazarus AH Transfus Med Rev; 2008 Apr; 22(2):103-16. PubMed ID: 18353251 [TBL] [Abstract][Full Text] [Related]
47. Intravenous immunoglobulin therapy in dermatologic disorders. Cakmak SK; Gül U; Gönül M; Kiliç A; Soylu S Inflamm Allergy Drug Targets; 2008 Jun; 7(2):75-84. PubMed ID: 18691136 [TBL] [Abstract][Full Text] [Related]
48. 7th International Immunoglobulin Conference: Mechanisms of action. Basta M; Branch DR Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):111. PubMed ID: 25546783 [TBL] [Abstract][Full Text] [Related]
50. [Use of intravenous immunoglobulins in pediatrics]. Duse M; Plebani A; Crispino P; Ugazio AG Pediatr Med Chir; 1991; 13(2):117-25. PubMed ID: 1896376 [TBL] [Abstract][Full Text] [Related]
51. Intravenous Immunoglobulin in the Treatment of Hematologic Disorders in Pediatrics. Villanueva G; de Jong JL; McNeer JL Pediatr Ann; 2017 Jan; 46(1):e13-e18. PubMed ID: 28079913 [TBL] [Abstract][Full Text] [Related]
52. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections. Günther G; Dreger B Microbiol Immunol; 2013 Jul; 57(7):527-35. PubMed ID: 23607863 [TBL] [Abstract][Full Text] [Related]
53. Hematologic toxicities associated with intravenous immunoglobulin therapy. Baxley A; Akhtari M Int Immunopharmacol; 2011 Nov; 11(11):1663-7. PubMed ID: 21843660 [TBL] [Abstract][Full Text] [Related]
54. Mechanisms of action of intravenous immunoglobulin (IVIG). Kazatchkine MD; Bellon B; Kaveri SV Mult Scler; 2000 Oct; 6 Suppl 2():S24-6; discussion S33. PubMed ID: 11188775 [TBL] [Abstract][Full Text] [Related]
55. Idiotype-specific intravenous immunoglobulin (IVIG) for therapy of autoimmune diseases. Blank M; Bashi T; Shoenfeld Y Methods Mol Biol; 2014; 1060():353-61. PubMed ID: 24037850 [TBL] [Abstract][Full Text] [Related]
56. Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms. Bayry J; Dasgupta S; Misra N; Ephrem A; Duong Van Huyen JP; Delignat S; Hassan G; Caligiuri G; Nicoletti A; Lacroix-Desmazes S; Kazatchkine MD; Kaveri S Int Immunopharmacol; 2006 Apr; 6(4):528-34. PubMed ID: 16504915 [TBL] [Abstract][Full Text] [Related]
57. Impact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms. Wong PH; White KM Clin Rev Allergy Immunol; 2016 Dec; 51(3):303-314. PubMed ID: 26142065 [TBL] [Abstract][Full Text] [Related]
58. [The use of IVIG in pediatric oncohematology and hematopoietic stem cell transplantation]. Kałwak K Pol Merkur Lekarski; 2011 Jun; 30(180):405-8. PubMed ID: 21751548 [TBL] [Abstract][Full Text] [Related]